Phage Therapy in the United States: What Are Your Options?

Phage therapy is gaining attention as a powerful alternative to antibiotics—but access in the United States remains extremely limited. For patients dealing with chronic or treatment-resistant infections, understanding your options is critical.

This page explains what’s currently available, what’s not, and how Induced Native Phage Therapy (INPT) at Biologix Center offers a completely different—and more accessible—approach.

What Is Phage Therapy?

Phage therapy is the use of bacteriophages—viruses that naturally infect and break down bacteria—to help the body eliminate microbial infections. This approach has been used in parts of Europe and Asia for decades, particularly for antibiotic-resistant infections.

In the U.S., however, traditional phage therapy is still considered experimental and is generally only available through clinical trials or emergency FDA pathways.

Why Phage Therapy Isn’t Widely Available in the U.S.

Requires a perfect match between phage and bacteria
Limited phage libraries and production infrastructure
FDA regulations restrict broad clinical use
Used primarily in academic or hospital research settings

Even when available, traditional phage therapy often targets only one or two bacterial strains—and isn’t designed to address multi-system or chronic conditions.

What Makes INPT Different?

Induced Native Phage Therapy (INPT) doesn’t introduce foreign phages. Instead, it stimulates the native phages already in your body—through signal-based activation and daily doctor-guided protocols. This allows us to:

Target multiple infections in real time
Bypass the need for external phage matching
Adapt treatment based on your body’s feedback
Offer phage-related therapy legally and safely in the U.S.

INPT Is Available Today at Biologix Center

Biologix Center for Optimum Health, located in Franklin, Tennessee, is the only clinic in the United States offering INPT as part of a comprehensive chronic illness treatment program.

Patients travel from across the country—and internationally—for this unique care model that combines real-time diagnostics, full-body restoration, and native phage activation.

Who Might Consider INPT?

INPT may be a great fit if you are dealing with:

Chronic Lyme disease or co-infections
Mold illness or mycotoxin exposure
Long COVID or post-viral syndromes
Persistent UTIs or antibiotic-resistant infections
Unclear diagnoses with immune or microbial involvement

Unlike traditional phage therapy, INPT is not limited to narrow infection targets. It’s part of a systems-based approach to chronic healing.

FAQs About Phage Therapy in the U.S.

Can I get phage therapy from my doctor?

Unless your doctor is affiliated with a clinical trial or FDA emergency use program, traditional phage therapy is not widely available in the U.S.

Is INPT legal in the United States?

Yes. INPT uses non-invasive biological signal therapies and is offered within the Biologix Center’s established treatment protocols.

Does INPT work like traditional phage therapy?

INPT works differently by stimulating native phages rather than introducing foreign viruses. This provides greater precision, fewer risks, and better real-time adaptability.

Next Steps

Biologix Center may be the only place in the U.S. where you can experience phage-related therapy today—without waiting for approval, trials, or red tape.